SENSORIUM THERAPEUTICS INC

MEDFORD, MA · Founded 2021 · CIK 0001874823 · Biotech · Private

Novel CNS therapeutics derived from natural compounds

sensorium.bio →
Grants
$2.0M
2 awards
Sector median: 1
Raised
$39M
3 Form D · Feb 2025
20 months since last filing
Contracts
—
No federal contracts on record
Patents
40
3 granted · 37 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$9,000,000
Private capital raisedForm D · SEC$15,512,569
Federal grantDepartment of Health and Human Services · Phase II · A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment$502,499
Private capital raisedForm D · SEC$14,496,526
Federal grantDepartment of Health and Human Services · Phase II · A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment$1,517,441
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2124PERIOMICS CARE LLC——
2125Apricity Therapeutics——
2126Lygos, Inc.—$41M
2127SENSORIUM THERAPEUTICS INC—$39M
2128CMTX BIOTECH INC—$500K
2129ProMIS Neurosciences Inc.—$39M
2130CASI Pharmaceuticals, Inc.—$35M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Balkrishan GillDirector
  • Alexandra GlucksmannDirector · Executive Officer
  • Jacob HookerDirector · Executive Officer
  • Ryan KatzDirector
  • Kevin LalandeDirector
  • Jerrold RosenbaumDirector
  • Richard SimonDirector · Executive Officer
  • David SouthwellDirector
  • Pranav TadiExecutive Officer

Patents

USPTO · 3 granted of 40
  • Deuterated Forms Of Alkaloid Compounds And Therapeutic Uses Thereofapplication
  • Delivery Of Therapeutic Alkaloid Compoundsapplication
  • Therapeutic Alkaloid Compoundsapplication
  • Solid Forms Of Mesembrine And Therapeutic Uses Thereofapplication
  • Delivery Of Therapeutic Alkaloid Compoundsapplication
  • Therapeutic Alkaloid Compoundsapplication
  • Therapeutic Alkaloid Compoundsgranted
  • Delivery Of Therapeutic Alkaloid Compoundsapplication
  • Delivery Of Therapeutic Alkaloid Compoundsgranted
  • Solid Forms Of Mesembrine And Therapeutic Uses Thereofapplication
  • Therapeutic Alkaloid Compoundsapplication
  • Delivery Of Therapeutic Alkaloid Compoundsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.